Treatment outcome with radiation therapy after breast augmentation or reconstruction in patients with primary breast carcinoma
โ Scribed by Sandra J. Victor; Douglas M. Brown; Eric M. Horwitz; Alvaro A. Martinez; Vijay R. Kini; Jane E. Pettinga; Kenneth W. Shaheen; Pamela Benitez; Peter Y. Chen; Frank A. Vicini
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 81 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
RESULTS.
With a median follow-up of 32 months, good/excellent cosmetic results were observed in 71% of patients (100% in those with augmented breasts and 54%
๐ SIMILAR VOLUMES
## Background: Controversy exists concerning the roles of mammography and physical examination in the detection of local recurrence after conservation therapy for breast carcinoma. in addition, the prognostic factors for and optimal treatment of patients with local recurrence are uncertain. ## Met
## BACKGROUND. The intensity of angiogenesis, as measured by microvessel density, is a strong independent predictor of survival in breast carcinoma patients. The impact of chemotherapy and/or endocrine therapy on this process is unknown. ## METHODS. Histologic samples from patients randomized t
## Background: There is controversy regarding the effect of age on breast carcinoma, and previous analyses have often excluded the most elderly patients as well as those with advanced cancers. this study assessed treatment variations and outcome in relation to age for a complete series of patients
## Background: Screening and surveillance is increasing the detection of early stage breast carcinoma. the ability to predict accurately the response to adjuvant therapy (chemotherapy or tamoxifen therapy) or postlumpectomy radiation therapy in these patients can be vital to their survival, because
The objective of the current study was to evaluate the effectiveness and morbidity of primary axillary radiotherapy in breast-conserving therapy for postmenopausal, clinically axillary lymph node negative patients with early stage breast carcinoma. Between 1983-1997, 105 patients with clinically neg